CD40 (D8W3N) & CO-0115-594 SignalStar^™ Oligo-Antibody Pair

SignalStar multiplex immunohistochemistry (IHC) is an advanced technology for labeling multiple proteins simultaneously in tissue samples using specific primary antibodies and fluorescent detection reagents. This technology offers accuracy and reliability in visualizing and analyzing protein expression while maintaining spatial context and tissue architecture.

SignalStar Oligo-Antibody Pairs are compatible with the SignalStar Multiplex IHC Buffer Kits for use in fluorescent multiplex imaging experiments. This product includes the oligo-conjugated antibodies and complementary oligos required for labeling your target protein on up to 10 slides. SignalStar Multiplex IHC Buffer Kits are required to amplify and image the target signal. Multiple oligo-antibody pairs can be conveniently combined into a multiplex panel using the SignalStar Multiplex IHC Panel Builder. SignalStar Multiplex IHC Kits & Reagents are not compatible with all of Cell Signaling Technology^® products and protocols that are recommended for use in immunohistochemical assays.

CD40 (D8W3N) Rabbit mAb (SignalStar™ Conjugate 0115) recognizes endogenous levels of total CD40 protein.

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala135 of human CD40 protein.

CD40, also known as tumor necrosis factor receptor superfamily member 5 (TNFRSF5), is a type I transmembrane protein expressed on the surface of B cells and professional antigen-presenting cells of the immune system, as well as on several non-hematopoietic cell types and cancers (1-4). CD40 interacts with CD40 ligand (CD40L/TNFSF5), which is expressed primarily on activated T cells but has also been reported on blood platelets, mast cells, basophils, NK cells, and B cells (5). Upon engagement with CD40L, CD40 signals through TNF receptor associated factors and MAP kinase signaling pathways, resulting in a wide variety of immune and inflammatory responses, including dendritic cell activation and cross-presentation, T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation (6-8). The CD40/CD40L axis is essential for the initiation and progression of cellular and humoral adaptive immunity, and is an important area of interest in the study of tumor immunology, neurodegenerative diseases, vascular diseases, and inflammatory disorders (9-12).

1. Banchereau, J. et al. (1995) Adv Exp Med Biol 378, 79-83.
2. Cooke, P.W. et al. (1999) J Pathol 188, 38-43.
3. Hakkarainen, T. et al. (2003) Clin Cancer Res 9, 619-24.
4. Slobodova, Z. et al. (2011) Neoplasma 58, 189-97.
5. Gauchat, J.F. et al. (1993) FEBS Lett 315, 259-66.
6. Quezada, S.A. et al. (2004) Annu Rev Immunol 22, 307-28.
7. Spriggs, M.K. et al. (1992) J Exp Med 176, 1543-50.
8. Elgueta, R. et al. (2009) Immunol Rev 229, 152-72.
9. Korniluk, A. et al. (2014) Tumour Biol 35, 9447-57.
10. Townsend, K.P. et al. (2005) Eur J Immunol 35, 901-10.
11. Hassan, G.S. et al. (2012) Immunobiology 217, 521-32.
12. Zhang, B. et al. (2013) Immunol Lett 153, 58-61.